High Blood Pressure & Cardiovascular Prevention

, Volume 25, Issue 4, pp 391–399 | Cite as

Blood Pressure Control and Other Quality of Care Metrics for Patients with Obesity and Diabetes: A Population-Based Cohort Study

  • Jennifer T. Fink
  • Elizabeth M. Magnan
  • Heather M. Johnson
  • Lauren M. Bednarz
  • Glenn O. Allen
  • Robert T. Greenlee
  • Daniel M. Bolt
  • Maureen A. SmithEmail author
Original Article



There are no population-level estimates in the United States for achievement of blood pressure goals in patients with diabetes and hypertension by obesity weight class.


We sought to examine the relationship between the extent of obesity and the achievement of guideline-recommended blood pressure goals and other quality of care metrics among patients with diabetes.


We conducted an observational population-based cohort study of electronic health data of three large health systems from 2010–2012 in rural, urban and suburban settings of 51,229 adults with diabetes. Outcomes were achievement of diabetes quality of care metrics: blood pressure, A1c, and LDL control, and A1c and LDL testing. Two blood pressure goals were examined given the recommendation for adults with diabetes of 130/80 mmHg from JNC7 and the recommendation of 140/90 mmHg from JNC8 in 2014.


Patients in obesity classes I, II, and III with diagnosed hypertension were less likely to achieve blood pressure control at both the 140/90 mmHg and 130/80 mmHg control levels. The patients from obesity class III had the lowest likelihood of achieving control at the 130/80 mmHg goal, and control was markedly worse for the 130/80 mmHg threshold in all weight classes. There were minimal to no differences by weight class in LDL and A1c control and LDL and A1c testing.


Although the cardiovascular risk for patients with obesity and diabetes is greater than for non-obese patients with diabetes, we found that patients with obesity are even further behind in achieving blood pressure control.


Hypertension Obesity Diabetes Blood pressure Cardiovascular risk 


Compliance with Ethical Standards


This study was funded by Grant R21 HS021899 from the Agency for Healthcare Research and Quality. Additional support was provided by the Health Innovation Program, the University of Wisconsin School of Medicine and Public Health from The Wisconsin Partnership Program, and the Community-Academic Partnerships core of the University of Wisconsin Institute for Clinical and Translational Research (UW ICTR) through the National Center for Advancing Translational Sciences (NCATS), Grant UL1TR000427. Dr. Magnan was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR000002 and linked award KL2TR001859. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.


  1. 1.
    Centers for Disease Control and Prevention: Diagnosed Diabetes. Accessed 4 Apr 2017.
  2. 2.
    Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes. 2013;6:327–38.CrossRefPubMedCentralPubMedGoogle Scholar
  3. 3.
    Zanella MT, Kohlmann O Jr, Ribeiro AB. Treatment of obesity hypertension and diabetes syndrome. Hypertension. 2001;38:705–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Sowers JR. Diabetes mellitus and vascular disease. Hypertension. 2013;61:943–7.CrossRefPubMedCentralPubMedGoogle Scholar
  5. 5.
    Saydah S, Bullard KM, Cheng Y, Ali MK, Gregg EW, Geiss L, Imperatore G. Trends in cardiovascular disease risk factors by obesity level in adults in the United States, NHANES 1999–2010. Obesity (Silver Spring). 2014;22:1888–95.CrossRefPubMedCentralGoogle Scholar
  6. 6.
    Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35:1364–79.CrossRefPubMedCentralPubMedGoogle Scholar
  7. 7.
    Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–52.CrossRefPubMedGoogle Scholar
  8. 8.
    James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–20.CrossRefPubMedGoogle Scholar
  9. 9.
    Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–115.PubMedGoogle Scholar
  10. 10.
    Jesky MD, Hayer MK, Thomas M, Dasgupta I. Do obese individuals with hypertension have more difficult-to-control blood pressure and end organ damage than their nonobese counterparts? J Clin Hypertens (Greenwich). 2015;17:466–72.CrossRefGoogle Scholar
  11. 11.
    Landsberg L, Aronne LJ, Beilin LJ, Burke V, Igel LI, Lloyd-Jones D, Sowers J. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment–a position paper of the The Obesity Society and The American Society of Hypertension. Obesity (Silver Spring). 2013;21:8–24.CrossRefGoogle Scholar
  12. 12.
    Ying A, Arima H, Czernichow S, Woodward M, Huxley R, Turnbull F, Perkovic V, Neal B. Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials. Lancet. 2015;385:867–74.CrossRefPubMedGoogle Scholar
  13. 13.
    American Diabetes Association: Statistics About Diabetes. Accessed 4 Apr 2017.
  14. 14.
    Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Nunez L, Gudbjornsdottir S, Eliasson B. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia. 2009;52:65–73.CrossRefPubMedGoogle Scholar
  15. 15.
    Lavie CJ, McAuley PA, Church TS, Milani RV, Blair SN. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol. 2014;63:1345–54.CrossRefPubMedGoogle Scholar
  16. 16.
    Chang VW, Asch DA, Werner RM. Quality of care among obese patients. JAMA. 2010;303:1274–81.CrossRefPubMedGoogle Scholar
  17. 17.
    Nguyen NT, Nguyen XM, Lane J, Wang P. Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999–2006. Obes Surg. 2011;21:351–5.CrossRefPubMedGoogle Scholar
  18. 18.
    Olszanecka-Glinianowicz M, Zygmuntowicz M, Owczarek A, Elibol A, Chudek J. The impact of overweight and obesity on health-related quality of life and blood pressure control in hypertensive patients. J Hypertens. 2014;32:397–407.CrossRefPubMedGoogle Scholar
  19. 19.
    Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J. Measurement of blood pressure in the office: recognizing the problem and proposing the solution. Hypertension. 2010;55:195–200.CrossRefPubMedGoogle Scholar
  20. 20.
    Powers BJ, Olsen MK, Smith VA, Woolson RF, Bosworth HB, Oddone EZ. Measuring blood pressure for decision making and quality reporting: where and how many measures? Ann Intern Med. 2011;154:781–8, W-289-90.CrossRefPubMedGoogle Scholar
  21. 21.
    Kallioinen N, Hill A, Horswill MS, Ward HE, Watson MO. Sources of inaccuracy in the measurement of adult patients’ resting blood pressure in clinical settings: a systematic review. J Hypertens. 2017;35:421–41.CrossRefPubMedGoogle Scholar
  22. 22.
    Gourevitch MN. Population health and the academic medical center: the time is right. Acad Med. 2014;89:544–9.CrossRefPubMedCentralPubMedGoogle Scholar
  23. 23.
    Bardach NS, Wang JJ, De Leon SF, Shih SC, Boscardin WJ, Goldman LE, Dudley RA. Effect of pay-for-performance incentives on quality of care in small practices with electronic health records: a randomized trial. JAMA. 2013;310:1051–9.CrossRefPubMedCentralPubMedGoogle Scholar
  24. 24.
    U.S. Department of Health & Human Services HRaSA. Performance Management and Measurement; 2011. Report No.
  25. 25.
    National Committee for Quality Assurance: Measuring Quality. Accessed 6 Sept 2018.
  26. 26.
    Wisconsin Collaborative for Healthcare Quality. WCHQ ambulatory measure specification: Diabetes care performance measures. Middleton; 2011. Report No.Google Scholar
  27. 27.
    Borzecki AM, Wong AT, Hickey EC, Ash AS, Berlowitz DR. Identifying hypertension-related comorbidities from administrative data: what’s the optimal approach? Am J Med Qual. 2004;19:201–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Magnan EM, Palta M, Mahoney JE, Pandhi N, Bolt DM, Fink J, Greenlee RT, Smith MA. The relationship of individual comorbid chronic conditions to diabetes care quality. BMJ Open Diabetes Res Care. 2015;3:e000080.CrossRefPubMedCentralPubMedGoogle Scholar
  29. 29.
    Tu K, Campbell NR, Chen ZL, Cauch-Dudek KJ, McAlister FA. Accuracy of administrative databases in identifying patients with hypertension. Open Med. 2007;1:e18–26.PubMedCentralPubMedGoogle Scholar
  30. 30.
    National Committee for Quality Assurance. The State of Health Care Quality 2011: Continuous Improvement and the Expansion of Quality Measurement. Washington DC; 2011. Report No.Google Scholar
  31. 31.
    World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: WHO Press; 2009.Google Scholar
  32. 32.
    Hsu WC, Araneta MR, Kanaya AM, Chiang JL, Fujimoto W. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care. 2015;38:150–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.CrossRefPubMedGoogle Scholar
  34. 34.
    Starfield B, Weiner J, Mumford L, Steinwachs D. Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv Res. 1991;26:53–74.PubMedCentralPubMedGoogle Scholar
  35. 35.
    Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health. 1997;18:341–78.CrossRefPubMedGoogle Scholar
  36. 36.
    Hart LG, Larson EH, Lishner DM. Rural definitions for health policy and research. Am J Public Health. 2005;95:1149–55.CrossRefPubMedCentralPubMedGoogle Scholar
  37. 37.
    Flack JM, Casciano R, Casciano J, Doyle J, Arikian S, Tang S, Arocho R. Cardiovascular disease costs associated with uncontrolled hypertension. Manag Care Interface. 2002;15:28–36.PubMedGoogle Scholar
  38. 38.
    Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, Narayan KM, Williamson DF. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005;293:1868–74.CrossRefPubMedGoogle Scholar
  39. 39.
    Bramlage P, Pittrow D, Wittchen HU, Kirch W, Boehler S, Lehnert H, Hoefler M, Unger T, Sharma AM. Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens. 2004;17:904–10.CrossRefPubMedGoogle Scholar
  40. 40.
    Parker ED, Sinaiko AR, Kharbanda EO, Margolis KL, Daley MF, Trower NK, Sherwood NE, Greenspan LC, Lo JC, Magid DJ, O’Connor PJ. Change in weight status and development of hypertension. Pediatrics. 2016;137:e20151662.CrossRefPubMedCentralPubMedGoogle Scholar
  41. 41.
    Wang J, Zhu Y, Jing J, Chen Y, Mai J, Wong SH, O’Reilly J, Ma L. Relationship of BMI to the incidence of hypertension: a 4 years’ cohort study among children in Guangzhou, 2007–2011. BMC Public Health. 2015;15:782.CrossRefPubMedCentralPubMedGoogle Scholar
  42. 42.
    Horr S, Nissen S. Managing hypertension in type 2 diabetes mellitus. Best Pract Res Clin Endocrinol Metab. 2016;30:445–54.CrossRefPubMedGoogle Scholar
  43. 43.
    Booth HP, Prevost AT, Gulliford MC. Severity of obesity and management of hypertension, hypercholesterolaemia and smoking in primary care: population-based cohort study. J Hum Hypertens. 2016;30:40–5.CrossRefPubMedGoogle Scholar
  44. 44.
    Bastien M, Poirier P, Lemieux I, Despres JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56:369–81.CrossRefPubMedGoogle Scholar
  45. 45.
    DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol. 2014;10:364–76.CrossRefPubMedCentralPubMedGoogle Scholar
  46. 46.
    Bertoni AG, Clark JM, Feeney P, Yanovski SZ, Bantle J, Montgomery B, Safford MM, Herman WH, Haffner S. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study. J Diabetes Complicat. 2008;22:1–9.CrossRefPubMedGoogle Scholar
  47. 47.
    Pham HH, Schrag D, O’Malley AS, Wu B, Bach PB. Care patterns in Medicare and their implications for pay for performance. N Engl J Med. 2007;356:1130–9.CrossRefPubMedGoogle Scholar
  48. 48.
    Staessen JA, Den Hond E, Celis H, Fagard R, Keary L, Vandenhoven G, O’Brien ET. Antihypertensive treatment based on blood pressure measurement at home or in the physician’s office: a randomized controlled trial. JAMA. 2004;291:955–64.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Jennifer T. Fink
    • 1
    • 2
  • Elizabeth M. Magnan
    • 3
  • Heather M. Johnson
    • 4
  • Lauren M. Bednarz
    • 5
    • 6
  • Glenn O. Allen
    • 7
  • Robert T. Greenlee
    • 8
  • Daniel M. Bolt
    • 9
  • Maureen A. Smith
    • 5
    • 6
    • 10
    Email author
  1. 1.Department of Health Informatics and Administration, College of Health SciencesUniversity of Wisconsin-MilwaukeeMilwaukeeUSA
  2. 2.Aurora Research Institute, Aurora Health CareMilwaukeeUSA
  3. 3.Department of Family and Community MedicineUniversity of California, DavisSacramentoUSA
  4. 4.Department of MedicineUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  5. 5.Health Innovation ProgramUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  6. 6.Department of Population Health SciencesUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  7. 7.Department of UrologyUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  8. 8.Center for Clinical Epidemiology and Population HealthMarshfield Clinic Research InstituteMarshfieldUSA
  9. 9.Department of Educational PsychologyUniversity of Wisconsin School of EducationMadisonUSA
  10. 10.Department of Family Medicine and Community HealthUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA

Personalised recommendations